Login / Signup

Thrombopoietin receptor agonists and rituximab for treatment of pediatric immune thrombocytopenia: A systematic review and meta-analysis of prospective clinical trials.

Nardeen Essam AyadRachael F F GraceDavid J Kuter
Published in: Pediatric blood & cancer (2021)
In this analysis of prospective pediatric ITP studies, RTX and TPO-RAs had similar rates of overall platelet response but differed in other important measures. Prospective comparative studies are needed to better characterize second-line treatments for pediatric ITP.
Keyphrases
  • clinical trial
  • case control
  • diffuse large b cell lymphoma
  • randomized controlled trial
  • open label
  • study protocol
  • smoking cessation